Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Thyroscope and TORC Announce Strategic Collaboration to Advance AI-Driven Precision Medicine in Thyroid Eye Disease


      News provided by

      Thyroscope

      Nov 17, 2026, 08:00 ET

      Share this article

      Share this article


      Smartphone monitoring, quantitative orbital imaging and clinical data will support a planned longitudinal study and a TORC-led research database.

      SEOUL, South Korea, Nov. 17, 2026 /PRNewswire/ -- Thyroscope (THYROSCOPE INC.) and The Orbital Radiology Center (TORC) today announced a memorandum of understanding to investigate an integrated approach to monitoring thyroid eye disease (TED) using smartphone-based artificial intelligence, quantitative orbital imaging and longitudinal clinical data.

      Continue Reading
      Figure 1. Proposed multimodal TED research workflow. Glandy phone is from Thyroscope materials; CT and audiometry visuals are illustrative.
      Figure 1. Proposed multimodal TED research workflow. Glandy phone is from Thyroscope materials; CT and audiometry visuals are illustrative.
      Dr. Shoaib Ugradar (CEO, TORC)
      Dr. Shoaib Ugradar (CEO, TORC)
      Jamey Park (CEO, Thyroscope)
      Jamey Park (CEO, Thyroscope)

      Thyroscope will contribute its Glandy smartphone-based AI platform for monitoring patients between clinical visits, while TORC will provide quantitative orbital imaging expertise. Together, the partners will develop a multimodal TED research database integrating smartphone-based assessments, quantitative imaging and longitudinal clinical data. BioSight Innovations, also led by TORC CEO Dr. Shoaib Ugradar, will provide treatment sites, clinical assessments and longitudinal follow-up for the initial study.

      TORC has provided contracted imaging assessment services for four clinical trials sponsored by Viridian Therapeutics, Zenas BioPharma, Lassen Therapeutics and Immunovant, and for an Amgen post-marketing study. Its scientific work includes nine published papers on quantitative imaging in TED.

      Why Better Monitoring Matters

      TED is an autoimmune disease that can cause inflammation, proptosis, eyelid retraction, double vision and, in severe cases, irreversible vision loss. Despite expanding treatments, assessment still relies on scheduled clinic visits. Measurements such as proptosis and the Clinical Activity Score (CAS) may vary between assessors and do not fully capture changes within orbital tissues.

      The partners will study whether home measurements and imaging improve longitudinal assessment.

      Combining Complementary Technologies

      Thyroscope's Glandy TED suite uses smartphone images and patient-reported information to assess inflammatory activity (Glandy CAS), proptosis (Glandy EXO) and eyelid morphology (Glandy LID). Its clinician-facing Glandoc platform makes patient-generated information available for review between appointments. All three Glandy TED solutions have obtained medical device authorization in South Korea and CE marking under the European Medical Device Regulation (EU MDR).

      TORC analyzes orbital CT and MRI, clinical photographs and associated clinical data to quantify tissue morphology and volumetric change. Its imaging capabilities complement the more frequent external measurements that patients may collect at home.

      BioSight Innovations will provide the clinical infrastructure for treatment and longitudinal follow-up, including conventional pure-tone audiometry using SHOEBOX Audiometry.

      Initial 40-Patient Research Study

      The partners plan to begin a prospective longitudinal feasibility and validation study of approximately 40 patients receiving TED treatment at BioSight Innovations centers in Los Angeles in January 2027. Participants will be followed from treatment initiation until up to 12 months after treatment completion.

      The study will compare smartphone-derived assessments with clinician-performed measurements and examine relationships with quantitative orbital imaging where CT or MRI is clinically appropriate and available. It will explore changes in disease activity, proptosis, eyelid position, anatomical findings, treatment response and clinically confirmed recurrence.

      All participants will undergo conventional audiometry at BioSight using SHOEBOX Audiometry. These measurements will inform iterative development and evaluation of an investigational smartphone-based pure-tone hearing assessment integrated into Glandy. The study will assess agreement, distinguishing development from independent validation. The smartphone test is not intended to replace conventional audiometry.

      The initial study is designed to establish feasibility and measurement agreement, not to validate recurrence prediction or treatment-selection algorithms. Interim findings are targeted for the first quarter of 2028, depending on enrollment and data availability.

      Building a Multimodal TED Research Database

      TORC and Thyroscope plan to jointly develop a longitudinal, multimodal TED research database integrating orbital imaging, smartphone-based assessments, standardized clinical findings, treatment exposures, outcomes and audiometric data. Future phases may incorporate consented tissue-derived and molecular information and larger patient cohorts.

      The longer-term goal is to support studies of treatment response, disease recurrence, imaging biomarkers and potential predictors of therapeutic benefit.

      Subject to scientific validation and appropriate data governance, the resource could also support pharmaceutical research into reproducible clinical trial endpoints and patient stratification.

      Leadership Perspectives

      DR. SHOAIB UGRADAR

      CEO, TORC

      "Thyroid eye disease is entering a new era of targeted therapeutics, yet our ability to objectively characterize treatment response and predict recurrence remains limited," said Dr. Shoaib Ugradar, CEO of TORC. "By combining quantitative orbital imaging with measurements collected between visits, we hope to better understand how patients respond, why some relapse and how more personalized care might eventually be supported."

      JAEMY PARK

      CEO, Thyroscope

      "Combining Glandy's smartphone-based assessments with TORC's imaging expertise creates an opportunity to study thyroid eye disease more continuously," said Jaemy Park, CEO of Thyroscope. "We aim to make objective measurement more accessible while contributing patient-generated information to rigorous longitudinal research."

      About the Organizations

      Thyroscope is a South Korean medical technology company developing AI-based assessment and monitoring technologies for thyroid disorders. Its Glandy TED portfolio includes smartphone-based tools for disease activity, proptosis and eyelid assessment. Learn more at www.thyroscope.com/en.

      The Orbital Radiology Center (TORC) is a medical technology company specializing in AI-based quantitative orbital imaging and TED research. It provides contracted imaging assessment services to pharmaceutical development programs and is developing the longitudinal multimodal TED research database. Website: www.torc-research.com

      BioSight Innovations provides TED treatment services, standardized clinical assessments and follow-up, including SHOEBOX Audiometry. Website: www.biosightinnovations.com

      Research and Regulatory Information

      The memorandum of understanding is non-binding, and the study and database remain planned initiatives. Glandy authorizations and certifications vary by product and jurisdiction; authorization outside the United States does not constitute US FDA clearance. Investigational technologies have not been established as substitutes for clinical examination or conventional audiometry.

      Study activities and research data use will be subject to applicable approvals, consent and privacy safeguards. The named pharmaceutical companies do not sponsor or endorse this collaboration by virtue of their separate contractual relationships with TORC. Dr. Ugradar leads both TORC and BioSight Innovations.

      SOURCE Thyroscope

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.